KoBioLabs, Inc (KOSDAQ:348150)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,900.00
+25.00 (0.51%)
At close: May 12, 2025, 3:30 PM KST
-35.70%
Market Cap 96.32B
Revenue (ttm) 68.36B
Net Income (ttm) -5.30B
Shares Out 19.42M
EPS (ttm) -276.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 16,670
Average Volume 121,790
Open 4,950.00
Previous Close 4,875.00
Day's Range 4,800.00 - 4,950.00
52-Week Range 3,730.00 - 8,920.00
Beta 0.70
RSI 47.69
Earnings Date May 15, 2025

About KoBioLabs

KoBioLabs, Inc. provides microbiome therapeutics for metabolic, immune, and neurological diseases. The company is based in Seongnam-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
CEO GwangPyo Ko
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 348150
Full Company Profile

Financial Performance

In 2024, KoBioLabs's revenue was 68.36 billion, an increase of 106.28% compared to the previous year's 33.14 billion. Losses were -5.30 billion, -61.76% less than in 2023.

Financial Statements

News

There is no news available yet.